1. SSRIs and persistent pulmonary hypertension of the newborn

   Unknown 08 February 2014 Pages: 1 - 1

2. Packaging defects cause for voluntary recall of Liptruzet

   Media release 08 February 2014 Pages: 2 - 2

3. HLA-B*1502 testing advised for Asian carbamazepine recipients

   News item 08 February 2014 Pages: 2 - 2

4. EFFIENT (prasugrel): timing of loading dose and risk of bleeding

   Unknown 08 February 2014 Pages: 2 - 2

5. Diane-35 back on the market in France

   Media release 08 February 2014 Pages: 2 - 2

6. vigiGrade completeness score assesses case report quality

   Unknown 08 February 2014 Pages: 3 - 3

7. Future oversight of rDNA research re-assessed

   Clinical study 08 February 2014 Pages: 3 - 3

8. Improving communication of important safety information

   Unknown 08 February 2014 Pages: 3 - 3

9. Genetic test to predict suicidality with antidepressant use

   Media release 08 February 2014 Pages: 4 - 4

10. Etomidate induction increases risk of death compared with propofol

    Epidemiology clinical study 08 February 2014 Pages: 4 - 4

11. Green tea reduces plasma concentration of nadolol

    Unknown 08 February 2014 Pages: 4 - 4

12. Fungal endophthalmitis associated with compounded products

    Unknown 08 February 2014 Pages: 4 - 4

13. Resident hand-off programme reduces medical errors

    Clinical study 08 February 2014 Pages: 5 - 5

14. Alendronic acid/prednisolone

    Case report 08 February 2014 Pages: 6 - 6

15. Acitretin

    Case report 08 February 2014 Pages: 6 - 6

16. Agomelatine

    Case report 08 February 2014 Pages: 6 - 6

17. Acetazolamide

    Case report 08 February 2014 Pages: 6 - 6

18. Allopurinol

    Case report 08 February 2014 Pages: 6 - 6

19. Amiodarone

    Case report 08 February 2014 Pages: 7 - 7

20. Amiodarone

    Case report 08 February 2014 Pages: 7 - 7

21. Aluminium acetotartrate

    Case report 08 February 2014 Pages: 7 - 7

22. Amiodarone/dabigatran etexilate

    Case report 08 February 2014 Pages: 7 - 7

23. Amoxicillin/clavulanic acid

    Case report 08 February 2014 Pages: 8 - 8

24. Antineoplastics

    Case report 08 February 2014 Pages: 8 - 8

25. Antihyperglycaemics/HMG-CoA reductase inhibitors

    Case report 08 February 2014 Pages: 8 - 8

26. Amlodipine/ciclosporin

    Case report 08 February 2014 Pages: 8 - 8

27. Aripiprazole

    Case report 08 February 2014 Pages: 9 - 9

28. Aspirin/clopidogrel

    Case report 08 February 2014 Pages: 9 - 9

29. Antipsychotics/propofol/suxamethonium chloride

    Case report 08 February 2014 Pages: 9 - 9

30. Antiretrovirals/prednisone

    Case report 08 February 2014 Pages: 9 - 9

31. Aspirin/fluindione

    Case report 08 February 2014 Pages: 10 - 10

32. Azathioprine

    Case report 08 February 2014 Pages: 10 - 10

33. Atracurium besilate

    Case report 08 February 2014 Pages: 10 - 10

34. Azathioprine

    Case report 08 February 2014 Pages: 10 - 10

35. BCG vaccine

    Case report 08 February 2014 Pages: 10 - 10

36. Bleomycin

    Case report 08 February 2014 Pages: 11 - 11

37. Bevacizumab

    Case report 08 February 2014 Pages: 11 - 11

38. Bleomycin

    Case report 08 February 2014 Pages: 11 - 11

39. Bupropion/citalopram/tramadol

    Case report 08 February 2014 Pages: 11 - 11

40. Buprenorphine

    Case report 08 February 2014 Pages: 11 - 11

41. Carbamazepine

    Case report 08 February 2014 Pages: 12 - 12

42. Carbamazepine/fluoxetine/oxazepam/quetiapine/sodium valproate overdose

    Case report 08 February 2014 Pages: 12 - 12

43. Cefepime

    Case report 08 February 2014 Pages: 12 - 12

44. Carbamazepine

    Case report 08 February 2014 Pages: 12 - 12

45. Candesartan cilexetil/dabigatran etexilate/paracetamol

    Case report 08 February 2014 Pages: 12 - 12

46. Cefepime

    Case report 08 February 2014 Pages: 12 - 12

47. Ceftriaxone

    Case report 08 February 2014 Pages: 13 - 13

48. Clomipramine/paroxetine

    Case report 08 February 2014 Pages: 13 - 13

49. Clopidogrel

    Case report 08 February 2014 Pages: 13 - 13

50. Ciprofloxacin/clozapine interaction

    Case report 08 February 2014 Pages: 13 - 13